We Announce role as Strategic Advisor to Gener8 on its Acquisition of Symbient

Alira Health’s Strategy Consulting and Transaction Advisory practices collaborate to help Gener8 grow beyond its core business.

News
Published on:
March 11, 2020

MUNICH, GERMANY – MARCH 11, 2020 – Alira Health (www.alirahealth.com), a leading international healthcare and life sciences advisory firm, was selected as the strategic advisor to Gener8, a Sunnyvale, California-based engineering and manufacturing firm serving the life sciences and medical device industries, in their acquisition of Symbient Product Development, LLC, a leading provider of design engineering for polymer life sciences consumables, based in Carlsbad, California. Gener8 is a portfolio company of Sverica Capital Management LP.

“The team at Symbient has built a tremendous business, taking on high complexity engineering projects with best-in-class turnaround times,” said David Brakenwagen, Gener8 CEO. “We are already collaborating on a number of customer programs which are yielding great success and are excited to provide this differentiated end market solution with the decades of combined technology, know-how and experience.”

“We are proud to support Gener8 in a transaction that allows them to offer customers a complete turnkey instrument and consumable solution,” says Dr. Michal Raciborski, Partner, Alira Health. “Our Strategy Consulting practice performed a comprehensive commercial due diligence on Symbient and its major markets to support Gener8’s evaluation of the transaction’s commercial value proposition and related opportunities and risks. Our team is dedicated to identifying and executing on these types of synergistic opportunities that deliver long-term profitability and value for our clients.”

“Congratulations to Gener8 and Symbient on a transaction that will bring even greater innovation to the product development and contract manufacturing markets. We have unique expertise in the CDMO space with transaction and market knowledge and direct contact with major players and potential targets around the world,” says Carlo Stimamiglio, Partner, Alira Health. “Our strong track record in M&A and strategy consulting assignments makes Alira Health the ideal choice for clients who need support on the definition and implementation of their growth strategies.”

About Gener8:

Gener8, founded in 2002, offers full product lifecycle engineering and manufacturing for highly complex instruments and products within the highly regulated Life Sciences and Medical Device markets. The services that Gener8 provides allow for an agile and fast time to market solution that results in high reliability solutions for customers. With locations in Sunnyvale, CA and Boston, MA Gener8 operates in the corridors of innovation and maintains all industry specific certifications.

For more information, please visit www.gener8.net.

Related news

News February 7, 2023
The 2023 MedTech Contract Manufacturing Report is released in the U.S.
Alira Health, a global healthcare advisory, clinical research and technology company, announced today the release of the 2023 U.S. MedTech Contract Manufacturing Report in collaboration(...)
MedTech
Publications February 7, 2023
The 2023 U.S. Medtech Contract Manufacturing Report
Read this report to discover the trends in the world of medical device CDMOs and their meaning for the industry.
MedTech
Publications February 2, 2023
Outlook 2023: Firms Prepare For ‘World Where Health Care Has No Limits’
In the latest publication by Medtech Insights by Pharma Intelligence, executives at top device companies and other stakeholders share their expectations.
MedTech Pharma
News January 31, 2023
The Playbook for Patient Engagement in MedTech in the U.S. is Launched
The MedTech Patient Engagement Think Tank announced today the launch of the Playbook for Patient Engagement in MedTech in the U.S.
MedTech Patient Engagement
Publications January 31, 2023
A Playbook for Patient Engagement in MedTech in the U.S.
“A Playbook for Patient Engagement in MedTech in the U.S.” is a result of amalgamating ideas, research, findings, and forecasts from industry subject matter experts that together(...)
MedTech Patient Engagement
Publications January 19, 2023
Medical Device Regulation in 2023: A Window of Opportunity
We spoke with our team of regulatory experts about the recent news regarding the MDR and the opportunity it presents to device manufacturers in 2023.
Medical Devices MedTech Regulatory
Publications January 19, 2023
What’s Next for Diabetes: Patient Engagement, Personalization, and Usable Technology
Alira Health partnered with the ADA to support this conversation and explore the most important topics emerging from patients, physicians, specialists, and patient advocates including(...)
Clinical Trials Diabetes MedTech Patient Engagement
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.